中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
NASH
Cancer Lipid Metabolism and Oral Checkpoint Inhibitors
Viral Hepatitis/HIV/AIDS
Pipeline & Products
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
Voluntary Announcement - ASC40 (TVB-2640) Phase II NASH Trial Completed Patient Enrollment in China
2020-11-19
Announcement - Change in Use of Proceeds from the Global Offering
2020-11-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
2020-11-03
Next Day Disclosure Returns - Share Buyback
2020-10-27
Next Day Disclosure Returns - Share Buyback
2020-10-21
Next Day Disclosure Returns - Share Buyback
2020-10-19
Next Day Disclosure Returns - Share Buyback
2020-10-16
Next Day Disclosure Returns - Share Buyback
2020-10-15
Next Day Disclosure Returns - Share Buyback
2020-10-14
Next Day Disclosure Returns - Share Buyback
2020-10-12
«
3
4
5
6
»
